Toggle light / dark theme

Self-powered artificial synapse mimics human color vision

As artificial intelligence and smart devices continue to evolve, machine vision is taking an increasingly pivotal role as a key enabler of modern technologies. Unfortunately, despite much progress, machine vision systems still face a major problem: Processing the enormous amounts of visual data generated every second requires substantial power, storage, and computational resources. This limitation makes it difficult to deploy visual recognition capabilities in edge devices, such as smartphones, drones, or autonomous vehicles.

Interestingly, the human visual system offers a compelling alternative model. Unlike conventional machine vision systems that have to capture and process every detail, our eyes and brain selectively filter information, allowing for higher efficiency in visual processing while consuming minimal power.

Neuromorphic computing, which mimics the structure and function of biological neural systems, has thus emerged as a promising approach to overcome existing hurdles in computer vision. However, two major challenges have persisted. The first is achieving color recognition comparable to human vision, whereas the second is eliminating the need for external power sources to minimize energy consumption.

AI tool analyzes blood DNA fragments for faster, affordable cancer monitoring

Scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new artificial intelligence (AI)-based method called “Fragle” that makes tracking cancer easier and faster using blood tests.

Requiring only a small blood sample, this method analyzes the size of DNA fragments in the blood to reveal distinct patterns that differentiate cancer DNA from healthy DNA, helping doctors track cancer treatment response more accurately and frequently. The research was published in Nature Biomedical Engineering in March 2025.

Existing methods for measuring cancer DNA in the blood, also known as circulating tumor DNA (ctDNA), often require complex and expensive DNA sequencing to screen for common cancer mutations. However, because cancer mutations vary between patients, test results can be inconsistent, making it difficult for doctors to track cancer treatment response with blood tests effectively.

Big tech on a quest for ideal AI device

ChatGPT-maker OpenAI has enlisted the legendary designer behind the iPhone to create an irresistible gadget for using generative artificial intelligence (AI).

The ability to engage digital assistants as easily as speaking with friends is being built into eyewear, speakers, computers and smartphones, but some argue that the Age of AI calls for a transformational new gizmo.

“The products that we’re using to deliver and connect us to unimaginable technology are decades old,” former Apple chief design officer Jony Ive said when his alliance with OpenAI was announced.